Tag: treatments of pancreatic neuroendocrine tumors
![pfizer logo1](https://www.carcinoid.org/wp-content/uploads/2011/05/pfizer-logo1.jpeg)
Breaking News: FDA Approves Pfizer’s Sutent for Pancreatic NET Cancer Patients
May 20, 2011
The US Food and Drug Administration today announced approval of Pfizer’s Sutent (sunitinib) for advanced pancreatic neuroendocrine tumor cancer patients with tumors that cannot be removed by surgery or that have spread (metastasized) to …
READ MORE![Pfizer logo](https://www.carcinoid.org/wp-content/uploads/2011/05/pfizer-logo.jpeg)
Breaking News: FDA Approves Pfizer’s Sutent for Pancreatic NET Cancer Patients
May 20, 2011
The US Food and Drug Administration today announced approval of Pfizer’s Sutent (sunitinib) for advanced pancreatic neuroendocrine tumor cancer patients with tumors that cannot be removed by surgery or that have spread (metastasized) to …
READ MORE![Novartis logo](https://www.carcinoid.org/wp-content/uploads/2011/05/novartis-logo.gif)
Breaking News: FDA Approves Treatment for pNET Patients
May 5, 2011
For the first time in nearly three decades, there is a new treatment for pancreatic neuroendocrine tumor patients! The Food and Drug Administration (FDA) today announced its approval of Afinitor© for pNET patients. This is a milestone for the carcinoid/NET…
READ MORE